Piccini, M.; Pilerci, S.; Merlini, M.; Grieco, P.; Scappini, B.; Bencini, S.; Peruzzi, B.; Caporale, R.; Signori, L.; Pancani, F.;
et al. Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience. J. Clin. Med. 2021, 10, 1684.
https://doi.org/10.3390/jcm10081684
AMA Style
Piccini M, Pilerci S, Merlini M, Grieco P, Scappini B, Bencini S, Peruzzi B, Caporale R, Signori L, Pancani F,
et al. Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience. Journal of Clinical Medicine. 2021; 10(8):1684.
https://doi.org/10.3390/jcm10081684
Chicago/Turabian Style
Piccini, Matteo, Sofia Pilerci, Marta Merlini, Pietro Grieco, Barbara Scappini, Sara Bencini, Benedetta Peruzzi, Roberto Caporale, Leonardo Signori, Fabiana Pancani,
and et al. 2021. "Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience" Journal of Clinical Medicine 10, no. 8: 1684.
https://doi.org/10.3390/jcm10081684
APA Style
Piccini, M., Pilerci, S., Merlini, M., Grieco, P., Scappini, B., Bencini, S., Peruzzi, B., Caporale, R., Signori, L., Pancani, F., Vannucchi, A. M., & Gianfaldoni, G.
(2021). Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience. Journal of Clinical Medicine, 10(8), 1684.
https://doi.org/10.3390/jcm10081684
